about
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the rever...
Read More
3.44
-0.32
(-8.51%)
118.6K
XNAS Volume
High volume+loss today
XNAS 15 May, 2026 4:05 PM (EDT)
Board Meeting
The next board meeting for CervoMed Inc is on 19 May 2026 for the purpose of CervoMed Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..